Fibromyalgia in Patient With Impaired Fasting Glucose

N/ACompletedNCT03871946

Hitit University146 enrolled

Overview

To assess the frequency of fibromyalgia among women with impaired fasting glucose.

Objective: To assess the frequency of fibromyalgia among women with impaired fasting glucose. Materials and Methods: The sample was selected from the patients who applied to the Internal Medicine clinic and whose fasting blood glucose level were ≥100 and \<126 mg/dL in their routine examination \[Group1 \] and patients whose fasting blood glucose were less than 100 constituted the control group \[Group2 \]. Oral glucose tolerance test \[OGTT \] has been applied to patients with impaired fasting glucose and whose 2nd hour OGTT levels were under 140 has been included. Patients were evaluated in terms of fibromyalgia according to modified 2010 ACR Fibromiyalgia Criteria. Functional status was assessed by using the Fibromyalgia Impact Questionnaire \[FIQ \].

Study Type

OBSERVATIONAL

Enrollment

146

Conditions

Fibromyalgia

Interventions

oral glucose tolerance test (OGTT)DIAGNOSTIC_TEST

Implementation of OGTT: The patient was seated in a quiet room after 10-12 h of overnight fasting, and blood samples were drawn. Thereafter, 75 g glucose solution dissolved in 300 mL of water was administeredwithin 5 min. Two hours after this,another blood sample was drawn. During the test, the patient wasn't allowed to rest and eat, but not smoke.

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * the study group subjects: fasting blood glucose level was between 100 and 126 mg/dL; * the control group subjects: fasting blood glucose level was \< 100 mg/dL. Exclusion Criteria: * Patients with a severe systemic disease (chronic kidney disease, liver disease etc. ), * psychiatric disease, * hypothyroidism or hyperthyroidism, * any connective tissue disease * patients who used medications that influenced the fibromyalgia symptoms, such as analgesics, antidepressants, and anticonvulsive medications

Outcomes

Primary Outcomes

the frequency of fibromyalgia among women with impaired fasting glucose.

Moreover, a significantly higher proportion of Group 1 patients (26%, n = 19) than Group 2 patients (11%, n = 8) were diagnosed with FM

Time frame: 16 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.